Direct effects on human cardiomyocytes by cancer therapy with monoclonal antibodies to HER2/erbB2 are not related to apoptosis

被引：0
|
作者：
Zuppinger, C
Immer, F
Sawyer, DB
Suter, TM
机构：
[1] Univ Hosp, Dept Heart & Vessels, Bern, Switzerland
[2] Boston Univ, Sch Med, Cardiovasc Med Sect, Boston, MA 02118 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
456
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [31] Pan-cancer analysis of the influence of ERBB2 alteration on HER2 expression
    Lee, Taebum
    Shin, Sangwon
    Song, Heon
    Park, Seonwook
    Pereira, Sergio
    Yoo, Donggeun
    Ro, Juneyoung
    Moon, Jimin
    Cho, Soo Ick
    Ahn, Changho
    Ock, Chan-Young
    Ali, Siraj M.
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Synthesis and biological evaluation of selective ErbB2 (Her2) inhibitors for the treatment of cancer
    Kauffman, Goss S.
    Lippa, Blaise
    Arcari, Joel
    Kwan, Tricia A.
    Bhattacharya, Samit K.
    Pustilnik, Leslie R.
    Su, Chunyan
    Moyer, James D.
    Ma, Ling
    Campbell, Mary
    Steyn, Stefan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [33] Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.
    Bardelli, Alberto
    Siravegna, Giulia
    Sartore-Bianchi, Andrea
    Nagy, Rebecca J.
    Mussolin, Benedetta
    Cassingena, Andrea
    Martino, Cosimo
    Lonardi, Sara
    Zagonel, Vittorina
    Leone, Francesco
    Amatu, Alessio
    Trusolino, Livio
    Odegaard, Justin
    Lanman, Richard B.
    Marsoni, Silvia
    Siena, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] HER2 (ERBB2) Immunohistochemistry in Non-Small Cell Lung Cancer: Does Expression Correlate with ERBB2 Mutational Status?
    Cardillo, Anthony
    Kovar, Sierra
    Hicks, David
    Velez, Moises
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1094 - 1095
  • [35] HER2 (ERBB2) Immunohistochemistry in Non-Small Cell Lung Cancer: Does Expression Correlate with ERBB2 Mutational Status?
    Cardillo, Anthony
    Kovar, Sierra
    Hicks, David
    Velez, Moises
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1094 - 1095
  • [36] ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
    Joshi, Sunil K.
    Keck, Jamie M.
    Eide, Christopher A.
    Bottomly, Daniel
    Traer, Elie
    Tyner, Jeffrey W.
    McWeeney, Shannon K.
    Tognon, Cristina E.
    Druker, Brian J.
    LEUKEMIA, 2020, 34 (10) : 2798 - 2804
  • [37] Essential roles of Her2/erbB2 in cardiac development and function
    Negro, A
    Brar, BK
    Lee, KF
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 59: CARDIOVASCULAR ENDOCRINOLOGY & OBESITY, 2004, 59 : 1 - 12
  • [38] ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
    Sunil K. Joshi
    Jamie M. Keck
    Christopher A. Eide
    Daniel Bottomly
    Elie Traer
    Jeffrey W. Tyner
    Shannon K. McWeeney
    Cristina E. Tognon
    Brian J. Druker
    Leukemia, 2020, 34 : 2798 - 2804
  • [39] ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity
    Mikulicic, Snjezana
    Shamun, Merha
    Massenberg, Annika
    Franke, Anna-Lena
    Freitag, Kirsten
    Doering, Tatjana
    Strunk, Johannes
    Tenzer, Stefan
    Lang, Thorsten
    Florin, Luise
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] The past, present, and future of HER2 (ERBB2) in cancer: Approaches to molecular testing and an evolving role in targeted therapy
    Hechtman, Jaclyn F.
    Ross, Dara S.
    CANCER CYTOPATHOLOGY, 2019, 127 (07) : 428 - 431
12345